Karyopharm Therapeutics Inc.
Book Per Share
| Fiscal Year | Book Per Share | Cash Per Share |
|---|---|---|
| FY2021 | $-1.06 | $2.53 |
| FY2022 | $-0.20 | $1.65 |
| FY2023 | $-1.19 | $0.46 |
| FY2024 | $-22,000.83 | $7,389.24 |
| FY2025 | $-26,787.93 | $5,536.35 |
Book Per Share
| Fiscal Year | Book Per Share | Cash Per Share |
|---|---|---|
| FY2021 | $-1.06 | $2.53 |
| FY2022 | $-0.20 | $1.65 |
| FY2023 | $-1.19 | $0.46 |
| FY2024 | $-22,000.83 | $7,389.24 |
| FY2025 | $-26,787.93 | $5,536.35 |